Population
Human and mouse plasma (in vitro) and mice (in vivo)
Design
Preclinical
Follow-up
up to 15 minutes
Authors
Loading...
In vitro Factor Xa binding may mislead; leaves open endothelial modulation of coagulation in vivo.
In vivo, Factor Xa binds to specific thrombin-binding sites on endothelial cells, which alters its proteinase inhibitor specificity compared to in vitro conditions.
Fuchs et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: